These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 7897213)
1. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta. Jackson JR; Sathe G; Rosenberg M; Sweet R J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213 [TBL] [Abstract][Full Text] [Related]
2. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues. Wu H; Nie Y; Huse WD; Watkins JD J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035 [TBL] [Abstract][Full Text] [Related]
3. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region. Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513 [TBL] [Abstract][Full Text] [Related]
4. Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions. Finlay WJ; Cunningham O; Lambert MA; Darmanin-Sheehan A; Liu X; Fennell BJ; Mahon CM; Cummins E; Wade JM; O'Sullivan CM; Tan XY; Piche N; Pittman DD; Paulsen J; Tchistiakova L; Kodangattil S; Gill D; Hufton SE J Mol Biol; 2009 May; 388(3):541-58. PubMed ID: 19285987 [TBL] [Abstract][Full Text] [Related]
5. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen. Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973 [TBL] [Abstract][Full Text] [Related]
6. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies. Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144 [TBL] [Abstract][Full Text] [Related]
7. In vitro affinity maturation of a specificity-determining region-grafted humanized anticarcinoma antibody: isolation and characterization of minimally immunogenic high-affinity variants. De Pascalis R; Gonzales NR; Padlan EA; Schuck P; Batra SK; Schlom J; Kashmiri SV Clin Cancer Res; 2003 Nov; 9(15):5521-31. PubMed ID: 14654532 [TBL] [Abstract][Full Text] [Related]
8. Affinity maturation of a high-affinity human monoclonal antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affinity and broaden strain reactivity. Thompson J; Pope T; Tung JS; Chan C; Hollis G; Mark G; Johnson KS J Mol Biol; 1996 Feb; 256(1):77-88. PubMed ID: 8609615 [TBL] [Abstract][Full Text] [Related]
9. Neutralizing murine monoclonal antibodies to human IL-5 isolated from hybridomas and a filamentous phage Fab display library. Ames RS; Tornetta MA; McMillan LJ; Kaiser KF; Holmes SD; Appelbaum E; Cusimano DM; Theisen TW; Gross MS; Jones CS J Immunol; 1995 Jun; 154(12):6355-64. PubMed ID: 7759873 [TBL] [Abstract][Full Text] [Related]
10. Isolation of picomolar affinity anti-c-erbB-2 single-chain Fv by molecular evolution of the complementarity determining regions in the center of the antibody binding site. Schier R; McCall A; Adams GP; Marshall KW; Merritt H; Yim M; Crawford RS; Weiner LM; Marks C; Marks JD J Mol Biol; 1996 Nov; 263(4):551-67. PubMed ID: 8918938 [TBL] [Abstract][Full Text] [Related]
11. Affinity maturation of a V(H)H by mutational hotspot randomization. Yau KY; Dubuc G; Li S; Hirama T; Mackenzie CR; Jermutus L; Hall JC; Tanha J J Immunol Methods; 2005 Feb; 297(1-2):213-24. PubMed ID: 15777944 [TBL] [Abstract][Full Text] [Related]
12. Contribution of heavy chain junctional amino acid diversity to antibody affinity among p-azophenylarsonate-specific antibodies. Parhami-Seren B; Margolies MN J Immunol; 1996 Sep; 157(5):2066-72. PubMed ID: 8757328 [TBL] [Abstract][Full Text] [Related]
13. Use of phage display for the generation of human antibodies that neutralize factor IXa function. Suggett S; Kirchhofer D; Hass P; Lipari T; Moran P; Nagel M; Judice K; Schroeder K; Tom J; Lowman H; Adams C; Eaton D; Devaux B Blood Coagul Fibrinolysis; 2000 Jan; 11(1):27-42. PubMed ID: 10691097 [TBL] [Abstract][Full Text] [Related]
14. Engineering a high-affinity anti-IL-15 antibody: crystal structure reveals an α-helix in VH CDR3 as key component of paratope. Lowe DC; Gerhardt S; Ward A; Hargreaves D; Anderson M; Ferraro F; Pauptit RA; Pattison DV; Buchanan C; Popovic B; Finch DK; Wilkinson T; Sleeman M; Vaughan TJ; Mallinder PR J Mol Biol; 2011 Feb; 406(1):160-75. PubMed ID: 21167836 [TBL] [Abstract][Full Text] [Related]
15. Generation of anti-p53 Fab fragments from individuals with colorectal cancer using phage display. Coomber DW; Hawkins NJ; Clark MA; Ward RL J Immunol; 1999 Aug; 163(4):2276-83. PubMed ID: 10438972 [TBL] [Abstract][Full Text] [Related]
16. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent. Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285 [TBL] [Abstract][Full Text] [Related]
17. Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection. Figini M; Obici L; Mezzanzanica D; Griffiths A; Colnaghi MI; Winter G; Canevari S Cancer Res; 1998 Mar; 58(5):991-6. PubMed ID: 9500461 [TBL] [Abstract][Full Text] [Related]
18. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold. Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968 [TBL] [Abstract][Full Text] [Related]
19. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains. van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026 [TBL] [Abstract][Full Text] [Related]
20. Humanization of an anti-human IL-6 mouse monoclonal antibody glycosylated in its heavy chain variable region. Sato K; Ohtomo T; Hirata Y; Saito H; Matsuura T; Akimoto T; Akamatsu K; Koishihara Y; Ohsugi Y; Tsuchiya M Hum Antibodies Hybridomas; 1996; 7(4):175-83. PubMed ID: 9140729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]